Linked e-resources
Details
Table of Contents
Chapter 1: Bioprocessing and analytical development for virus-based therapeutics
Chapter 2: Viral Vector Upstream Processing and Clarification
Chapter 3: Upstream processing of viral therapeutics: From host cell expansion to virus production
Chapter 4: Leveraging virus biology and host genetic conflicts for cell line development and engineering for virus-based therapeutics
Chapter 5: Overview of Current Downstream Processing for Modern Viral Vectors
Chapter 6: Filtration Principles and Techniques for Bioprocessing of Viral Vector–Based Therapeutics
Chapter 7: Chromatographic purification of viruses: State of the art and current trends
Chapter 8: Purifying Viral Vectors - A Review of Chromatography Solutions
Chapter 9: Particle analytics - Comparative approaches for analysis of viral vectors
Chapter 10: Phase-Appropriate Potency Assay Development for AAV-based Gene Therapy Products
Chapter 11: Quantification of virus infectivity – the key assay for the development of viral therapeutics
Chapter 12: Product-related impurities in therapeutic virus bioprocessing
Chapter 13: Process Analytical Technologies (PAT) and Quality by Design (QbD) for bioprocessing of virus-based therapeutics
Chapter 14: Methods and practical considerations in imaging viral therapeutics
Chapter 15: Application of NMR Spectroscopy in Viral Assembly Characterization
Chapter 16: Improved Production Strategies for Oncolytic Measles Viruses as a Therapeutic Cancer Treatment
Chapter 17: Recent Advancements and Challenges in Recombinant Expression for Commercial Production of Virus Like Particles (VLPs)
Chapter 18: Oncolytic viruses and viral gene therapy vectors: Principles of safety.
Chapter 2: Viral Vector Upstream Processing and Clarification
Chapter 3: Upstream processing of viral therapeutics: From host cell expansion to virus production
Chapter 4: Leveraging virus biology and host genetic conflicts for cell line development and engineering for virus-based therapeutics
Chapter 5: Overview of Current Downstream Processing for Modern Viral Vectors
Chapter 6: Filtration Principles and Techniques for Bioprocessing of Viral Vector–Based Therapeutics
Chapter 7: Chromatographic purification of viruses: State of the art and current trends
Chapter 8: Purifying Viral Vectors - A Review of Chromatography Solutions
Chapter 9: Particle analytics - Comparative approaches for analysis of viral vectors
Chapter 10: Phase-Appropriate Potency Assay Development for AAV-based Gene Therapy Products
Chapter 11: Quantification of virus infectivity – the key assay for the development of viral therapeutics
Chapter 12: Product-related impurities in therapeutic virus bioprocessing
Chapter 13: Process Analytical Technologies (PAT) and Quality by Design (QbD) for bioprocessing of virus-based therapeutics
Chapter 14: Methods and practical considerations in imaging viral therapeutics
Chapter 15: Application of NMR Spectroscopy in Viral Assembly Characterization
Chapter 16: Improved Production Strategies for Oncolytic Measles Viruses as a Therapeutic Cancer Treatment
Chapter 17: Recent Advancements and Challenges in Recombinant Expression for Commercial Production of Virus Like Particles (VLPs)
Chapter 18: Oncolytic viruses and viral gene therapy vectors: Principles of safety.